ÐÁ·¥ËûÍ¡ÖÎÁƶ¯ÂöµÄÖàÑùÓ²»¯°ß¿éÁÆÐ§¹Û²ì ÏÂÔØ±¾ÎÄ

ÄÚÈÝ·¢²¼¸üÐÂʱ¼ä : 2026/5/25 11:19:05ÐÇÆÚÒ» ÏÂÃæÊÇÎÄÕµÄÈ«²¿ÄÚÈÝÇëÈÏÕæÔĶÁ¡£

ÐÁ·¥ËûÍ¡ÖÎÁƶ¯ÂöÖàÑùÓ²»¯°ß¿éÁÆÐ§¹Û²ì

?

Ò©ÎïÓëÁÙ´²?2012Äê1ÔµÚ19¾íµÚ2ÆÚ ÐÁ·¥ËûÍ¡ÖÎÁƶ¯ÂöÖàÑùÓ²»¯°ß¿éÁÆÐ§¹Û²ì ²ÜÑÓ¼ª

ºÓÄÏÊ¡ÃÚÑôÏØÖÐÒ½Ôº.ºÓÄÏÃÚÑô463700

¡ºÕªÒª¡¿Ä¿µÄ:̽ÌÖÐÁ·¥ËûÍ¡ÖÎÁƶ¯ÂöÖàÑùÓ²»¯°ß¿éµÄÁÙ´²ÁÆÐ§.·½·¨:ѡȡ2010Äê1Ô¡«2011Äê6ÔÂÀ´±¾Ôº¾ÍÕïµÄ

60Àý¶¯ÂöÖàÑùÓ²»¯°ß¿é»¼Õß,½«ÆäËæ»ú·ÖΪ¹Û²ì×éºÍ¶ÔÕÕ×é¸÷30Àý,¶ÔÕÕ×黼Õ߸øÓèÒûʳ¿ØÖÆ,·ÇËûÍ¡ÀàÒ©ÎïÖÎ

ÁÆ,¹Û²ì×黼Õ߸øÓèÐÁ·¥ËûÍ¡40mg,1´Î/dI:1·þ,Á¬ÐøÖÎÁÆ18¸öÔÂ,·Ö±ð¹Û²ìµÚ6,12,18¸öÔºóÁ½×黼ÕßѪÉú»¯¸÷

ÏîÖ¸±êµÄ±ä»¯,¶¯ÂöÖàÑùÓ²»¯°ß¿éµÄ±ä»¯¼°ÑªÒºÁ÷±äѧ¸÷Ö¸±êµÄ±ä»¯.½á¹û:Á½×éÖÎÁƺó,×ܵ¨¹Ì´¼(TC),Èýõ£¸ÊÓÍ

(TG),µÍÃܶÈÖµµ°°×µ¨¹Ì´¼(LDL¡ªC)¾ùÓв»Í¬³Ì¶ÈµÄϽµ,¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼(HDL¡ªC)ÓÐËùÉÏÉý,Óëͬ×éÖÎÁÆÇ°

±È½Ï,¸÷ÏîÖ¸±ê²îÒì¾ù¾ßÓÐͳ¼ÆÑ§ÒâÒå(P<0.05),ÇÒÖÎÁÆ18¸öÔºóÁ½×é¼ä²îÒìÒà¾ßÓÐͳ¼ÆÑ§ÒâÒå(P<O.05);Á½×éÖÎ

Áƺó¶¯ÂöÖàÑùÓ²»¯°ß¿é¾ù¼õС,¹Û²ì×éÖÎÁÆ×ÜÓÐЧÂÊΪ93.33%,ÏÔןßÓÚ¶ÔÕÕ×éµÄ80.o0%,Á½×é¼ä²îÒìÓÐͳ¼ÆÑ§

ÒâÒå(P<O.05);Á½×éÖÎÁƺóѪҺÁ÷±äѧ¸÷Ö¸±ê¾ùÓÐÃ÷ÏÔϽµ,ÓëÖÎÁÆÇ°±È½Ï,²îÒìÓÐͳ¼ÆÑ§ÒâÒå(P<O.05),ÇÒÁ½×é¼ä

ͬһʱ¼ä±È½Ï,²îÒìÒàÓÐͳ¼ÆÑ§ÒâÒå(P<O.05).½áÂÛ:ÐÁ·¥ËûÍ¡ÖÎÁƶ¯ÂöÖàÑùÓ²»¯°ß¿é,ÁÆÐ§ÏÔ×Å,ÖµµÃÁÙ´²ÍƹãʹÓÃ.

f¹Ø¼ü´Ê¡¿ÐÁ·¥ËûÍ¡;¶¯ÂöÖàÑùÓ²»¯°ß¿é;ÁÆÐ§¹Û²ì;ѪҺÁ÷±äѧ fÖÐͼ·ÖÀàºÅ¡¿R972¡¾ÎÄÏ×±êʶÂë¡¿A¡¾ÎÄÕ±àºÅ¡¿1674¡ª4721(2012)01(b)Ò»066¡ª02

Efficacyobservationofsimvastatinintreatmentofatheroscleroticplaque CA0Yanji

ChineseMedcineHospitalofBiyangCountyinHenanProvince,Biyang463700,China ¡¾

Abstract

¡¿

Objective:Toobservethecurativeeffectsofsimvastatininthetreatmentofatheroscleroticplaque.Methods:

SixtypatientswithatheroscleroticplaquewereselectedfromJanuary2010toJune2011andweredividedintoobservation

groupandcontrolgroup30caseseach,thecontrolgroupweregivenalimentarycontrol,non-statindrugtreatment,theob-

servationgroupweregivensimvastatin40mgonceadayorally,andtwogroupswereallgiven18monthscontinuoustreat¡ª

ment.Bloodbiochemicalindicators,atheroscleroticplaquechangesandrheologyoftheindicatorswereobservedafter6,12

and18monthstreatments.Results:TC,TG,LDL-Coftwogroupsaftertreatmentswerealldecreased,HDL-Cincreased,

whichwerecomparedwithbeforetreatment,thedifierencesweresignificantfP<0.05),andafter18monthstreatment,there

weresignificantdifferencebetweentwogroups(P<0.05);atheroscleroticplaqueaftertreatmentwerealldecreasedofthe

twogroupsandthetotaleffectofobservationgroupwas93.33%.whichwasbetterthan80.00%ofthecontrolgroup.there wassignificantdifferencebetweentwogroups(

ʬ

l<0.05);rheologyoftheindicatorswerealldramaticlydeclined,whichwere comparedwithbeforetreatment,thedifferencesweresignificant<0.o5),andtherewerealsosignificantdifferencebe¡ª

tweentwogroupsatthesametime<0.05).Conclusion:Simvastatinhaspositivecurativeeffectsinthetreatmentof

atheroscleroticplaqueandbeworthyoffurtherclinicalusing. ¡¾

Keywords

¡¿

Simvastatin;Atheroscleroticplaque;Efficacyobservation;Hemorheology Ëæ×ÅÎÒ¹úÈËÃñÉú»îˮƽ,Ò½ÁÆÌõ¼þµÄ²»¶ÏÌá¸ß,Òûʳ½á ¹¹µÄ¸Ä±ä,¶¯ÂöÖàÑùÓ²»¯,¸ß֬Ѫ֢,ÌÇÄò²¡,´úл×ÛºÏÕ÷µÄ ·¢²¡ÂÊÒ²Ëæ×ÅÖðÄêÉý¸ßi1¡¿.¸ßѪѹºÍѪ֬Òì³£ÊÇÒýÆð¶¯ÂöÖà ÑùÓ²»¯µÄÖØÒªÒòËØ,Òò´Ë,½µµÍÈýõ£¸ÊÓͼ°Ñªð¤¶Èˮƽ,Ìá¸ß ¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼¶Ô·ÀÖ¹¶¯ÂöÖàÑùÓ²»¯ÓÐ×ÅÖØÒªµÄÒâÒå.